Chung AY - Search Results

1

Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma.

Jin Y, Lee WY, Toh ST, Tennakoon C, Toh HC, Chow PK, Chung AY, Chong SS, Ooi LL, Sung WK, Lee CG. Jin Y, et al. Among authors: chung ay. J Transl Med. 2019 Aug 20;17(1):273. doi: 10.1186/s12967-019-2025-x. J Transl Med. 2019. PMID: 31429776 Free PMC article.

2

Prevalence of Helicobacter pylori in gastric cancer in a South-East Asian population by 14C-urea breath test.

Chung AY, Chow PK, Yu WK, Ho JM, Chan HS, Wong WK, Soo KC. Chung AY, et al. ANZ J Surg. 2001 Oct;71(10):574-6. doi: 10.1046/j.1445-2197.2001.02208.x. ANZ J Surg. 2001. PMID: 11552930

3

Computed tomographic appearance of colorectal hepatic metastases.

Chiang SH, Thng CH, Teh CS, Tan AG, Poddar SL, Wong BS, Chow PK, Chung AY, Ooi LL. Chiang SH, et al. Among authors: chung ay. Ann Acad Med Singap. 2003 Mar;32(2):191-5. Ann Acad Med Singap. 2003. PMID: 12772522

4

Role of fenestration and resection for symptomatic solitary liver cysts.

Tan YM, Chung A, Mack P, Chow P, Khin LW, Ooi LL. Tan YM, et al. ANZ J Surg. 2005 Jul;75(7):577-80. doi: 10.1111/j.1445-2197.2005.03432.x. ANZ J Surg. 2005. PMID: 15972051

5

Factors affecting early mortality in spontaneous rupture of hepatocellular carcinoma.

Tan FL, Tan YM, Chung AY, Cheow PC, Chow PK, Ooi LL. Tan FL, et al. Among authors: chung ay. ANZ J Surg. 2006 Jun;76(6):448-52. doi: 10.1111/j.1445-2197.2006.03750.x. ANZ J Surg. 2006. PMID: 16768766

6

Adult choledochal cysts: an audit of surgical management.

Woon CY, Tan YM, Oei CL, Chung AY, Chow PK, Ooi LL. Woon CY, et al. Among authors: chung ay. ANZ J Surg. 2006 Nov;76(11):981-6. doi: 10.1111/j.1445-2197.2006.03915.x. ANZ J Surg. 2006. PMID: 17054547

7

Giant cystic colorectal liver metastasis: an unusual presentation.

Chung AY, Chui CH, Tan YM, Kwek BH, Tan HW, Thng CH, Toh HC. Chung AY, et al. Dig Dis Sci. 2007 Sep;52(9):2333-5. doi: 10.1007/s10620-005-9014-z. Epub 2007 Apr 11. Dig Dis Sci. 2007. PMID: 17429739 No abstract available.

8

Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.

Huynh H, Ngo VC, Fargnoli J, Ayers M, Soo KC, Koong HN, Thng CH, Ong HS, Chung A, Chow P, Pollock P, Byron S, Tran E. Huynh H, et al. Clin Cancer Res. 2008 Oct 1;14(19):6146-53. doi: 10.1158/1078-0432.CCR-08-0509. Clin Cancer Res. 2008. PMID: 18829493

9

Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.

Huynh H, Ngo VC, Koong HN, Poon D, Choo SP, Thng CH, Chow P, Ong HS, Chung A, Soo KC. Huynh H, et al. J Cell Mol Med. 2009 Aug;13(8B):2673-2683. doi: 10.1111/j.1582-4934.2009.00692.x. Epub 2009 Feb 9. J Cell Mol Med. 2009. PMID: 19220580 Free PMC article.

10

AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancer.

Yang S, Ngo VC, Lew GB, Chong LW, Lee SS, Ong WJ, Lam WL, Thng CH, Koong HN, Ong HS, Chung A, Chow P, Lee J, Soo KC, Huynh H. Yang S, et al. Mol Cancer Ther. 2009 Sep;8(9):2537-45. doi: 10.1158/1535-7163.MCT-09-0213. Epub 2009 Sep 1. Mol Cancer Ther. 2009. PMID: 19723882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters